Progress toward elimination of onchocerciasis in the Americas - 1993-2012

Morbidity and Mortality Weekly Report

Volumn 62, Issue 20, 2013, Pages 405-408

  Eberhard, Mark ^a  

^a PAN AMERICAN HEALTH ORGANIZATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPARASITIC AGENT; IVERMECTIN;

ARTICLE; GUATEMALA; HUMAN; MEXICO; ONCHOCERCIASIS; SOUTH AMERICA;

ANTIPARASITIC AGENTS; GUATEMALA; HUMANS; IVERMECTIN; MEXICO; ONCHOCERCIASIS, OCULAR; SOUTH AMERICA;

EID: 84878328410     PISSN: 01492195     EISSN: 1545861X     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Crump A, Morel CM, Omura S. The onchocerciasis chronicle: from the beginning to the end? Trends Parasitol 2012;28:208-88.
2. World Health Organization. Certification of elimination of human onchocerciasis: criteria and procedures. Geneva, Switzerland: World Health Organization; 2001. Available at http://whqlibdoc.who.int/hq/2001/WHO_CDS_CPE_CEE_2001.18b.pdf.
3. Lindblade KA, Arana B, Zea-Flores G, et al. Elimination of Onchocerca volvulus transmission in the Santa Rosa focus of Guatemala. Am J Trop Med Hyg 2007;77:334-41.
4. Program Coordinating Committee and OEPA staff. Guide to detecting a potential recrudescence of onchocerciasis during the posttreatment surveillance period: the American paradigm. Res Rep Trop Med 2012;3:21-33.
5. Blanks J, Richards F, Beltran F, et al. The Onchocerciasis Elimination Program of the Americas: a history of partnership. Rev Panam Salud Publica 1998;3:367-74.
6. Sauerbrey M. The Onchocerciasis Elimination Program for the Americas (OEPA). Ann Trop Med Parasitol 2008;102 (Suppl 1):S25-9.
7. World Health Organization. InterAmerican Conference on Onchocerciasis, 2011: interruption of transmission in Guatemala and Mexico. Wkly Epidemiol Rec 2012;87:309-15.